Overexpression of eIF3a in Squamous Cell Carcinoma of the Oral Cavity and Its Putative Relation to Chemotherapy Response

Table 2

Overall survival in months of patients receiving platinum-based chemotherapy (1) or not (0), with respect to their eIF3a expression status.

	eIF3a expression
	Low	High
Platinum-based; chemotherapy	Average overall survival (months)
1	67.2	27.9
0	53.3	35.7